Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients
- PMID: 608536
Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients
Abstract
Sixteen patients with disseminated melanoma were immunised with either BCG (8 cases) or C. parvum (8 cases) on three occasions at 21 day intervals. Blood for assay was taken immediately before the first immunisation and weekly for eight weeks thereafter. Total white count tended to increase but little change was seen in lymphocyte and monocyte counts. Serum IgG increased after BCG BUT NOT WITH C. parvum, serum IgA and IgM did not alter. The 'E' rosette % did show some increase mainly after C. parvum, and 'B' lymphoid cells (sIg staining) increased slightly after BCG; the 'EA' rosette % fell following C. parvum but not after BCG. Lymphocyte PHA blastogenesis increased after immunisation, particularly with BCG. Non-specific lymphocytotoxicity (51 Cr Chang target) demonstrated dramatic increases for 'non T' and 'K' cell function and a smaller increase in 'T' cell cytotoxicity following immunisation. These increases in cytotoxicity were maintained by the 21 day immunisation schedule.
Similar articles
-
Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations.Clin Exp Immunol. 1979 Jun;36(3):456-64. Clin Exp Immunol. 1979. PMID: 487647 Free PMC article.
-
Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations.Clin Exp Immunol. 1979 Jan;35(1):36-44. Clin Exp Immunol. 1979. PMID: 428146 Free PMC article.
-
Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions.Clin Exp Immunol. 1979 Feb;35(2):171-9. Clin Exp Immunol. 1979. PMID: 312169 Free PMC article.
-
Immunology and cutaneous malignant melanoma.Int J Dermatol. 1976 Jan-Feb;15(1):1-18. doi: 10.1111/j.1365-4362.1976.tb05089.x. Int J Dermatol. 1976. PMID: 1107238 Review. No abstract available.
-
The immune response in human malignant melanoma.Clin Exp Dermatol. 1976 Mar;1(1):23-8. doi: 10.1111/j.1365-2230.1976.tb01395.x. Clin Exp Dermatol. 1976. PMID: 773575 Review. No abstract available.
Cited by
-
Single versus multiple human-equivalent doses of C. parvum in mice: neutralization of the anti-metastatic effect.Br J Cancer. 1980 Mar;41(3):407-14. doi: 10.1038/bjc.1980.64. Br J Cancer. 1980. PMID: 7387830 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous